Aminase

  • Anorexia, PEM & PEW

Protein Energy Malnutrition and Protein Energy Wasting in Maintenance Haemo Dialysis & Peritoneal Dialysis, Cancer Induced Cachexia, Liver Cirrhosis and Elderly Patients

https://mylinbiotech.com/wp-content/uploads/2023/08/dna.png
Administered along with Protein
https://mylinbiotech.com/wp-content/uploads/2023/08/sales.png
Improves Albumin
Turnover
https://mylinbiotech.com/wp-content/uploads/2023/08/face-recognition.png
Addresses anorexia and reduces hsCRP.
https://mylinbiotech.com/wp-content/uploads/2023/08/full-time.png
Breaks Proteins in to Di &
Tri Peptides < 90 minutes

Dosage

Daily 1 capsule TID.

Direction

Direction : To be taken immediately after each meal. Avoid on an empty stomach.

  • Addresses Anorexia may be by regulating Leptin and Grehlin hormones.
  • Improves Albumin turnover and skeletal muscle mass

International Journal of Basic & Clinical Pharmacology

FAQs

What is the purpose and mechanism of action of Aminase 200mg capsules?

Aminase, a patented blend of proteolytic enzymes, is primarily used in Protein-Energy Wasting (PEW) and Protein-Energy Malnutrition (PEM) associated with conditions such as Chronic Kidney Disease (CKD), Liver Cirrhosis, Cancer Cachexia, Chronic Obstructive Pulmonary Disease (COPD), and Tuberculosis (TB) to promote skeletal mass buildup.

Aminase also serves as a potential therapy for addressing Anorexia. It exhibits the capability to balance the Grehlin and Leptin hormones, presenting a promising solution in the treatment of Anorexia.

Is Aminase safe?

Yes, Aminase is classified under the Generally Recognized as Safe (GRAS) category. The enzymes in Aminase are derived from a microbial source, and their long-term safety has been established through clinical trials.

What are the advantages of Aminase?

Here are the transformative benefits of Aminase:

  • Aminase elevates amino acid levels, effectively maintaining and enhancing albumin turnover in CKD patients when consumed alongside both vegetarian and non-vegetarian protein meals.
  • Aminase mitigates the decline in anthropometric parameters, such as Mid Arm Circumference.
  • Through clinical trials, Aminase has demonstrated an impressive 91% reduction in mortality risk compared to albumin levels, as published in the International Journal of Basic & Clinical Pharmacology in June 2019, Volume 8, Issue 6, on page 1424.
What is the scientific data supporting Aminase?

Explore the compelling scientific data backing Aminase, shedding light on its efficacy in addressing protein energy wasting in end-stage kidney disease and its impact on hemodialysis patients, as published in reputable journals:

  • Unravel the insights from research on combating protein energy wasting in end-stage kidney disease, elucidating the role of exogenous proteolytic enzymes as adjuvants to dietary protein. (Published in the International Journal of Basic & Clinical Pharmacology, June 2019, Vol 8, Issue 6, Page 1424.)
  • Explore the evaluation of proteolytic enzymes on hemodialysis patients with protein energy wasting and associated variables.
What precautions should be observed when taking Aminase?

To prevent severe gastrointestinal discomfort, always take Aminase immediately after having a protein-rich meal, and avoid taking it on an empty stomach.

What is the pack size and storage guidance for Aminase?

Aminase is packaged in boxes containing 28 capsules each and should be stored in a refrigerator at temperatures ranging from 2-25 degrees Celsius. However, if kept outside for a brief period, not exceeding 2-3 days (while strictly avoiding exposure to sunlight), the product remains stable.

Is Aminase patented?

Yes, Aminase has been granted a patent.